GFI1 Gene Neutropenia severe congenital type 2 autosomal dominant Genetic Test
Are you looking for a reliable genetic lab in UAE to conduct the GFI1 Gene Neutropenia severe congenital type 2 autosomal dominant Genetic Test? Look no further than DNA Labs UAE. Our lab offers comprehensive genetic testing services to help diagnose and manage various genetic disorders.
Test Details
The GFI1 gene is associated with a rare genetic disorder called severe congenital neutropenia type 2 (SCN2). This disorder is inherited in an autosomal dominant manner, which means that a mutation in one copy of the GFI1 gene is enough to cause the condition. Neutropenia refers to a low level of neutrophils, which are a type of white blood cell involved in fighting off infections. In SCN2, individuals have a severe form of neutropenia from birth, which makes them highly susceptible to recurrent bacterial infections.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes. In the case of SCN2, NGS genetic testing can be used to identify mutations in the GFI1 gene. This testing can help confirm a diagnosis and determine the specific mutation present in an affected individual or their family members. Knowing the specific mutation can be important for genetic counseling, as it can help predict the likelihood of passing the condition on to future generations. Additionally, it can aid in the development of personalized treatment strategies for individuals with SCN2.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Osteology Dermatology Immunology Disorders
Referring Doctor and Test Department
If you suspect that you or a family member may have GFI1 Gene Neutropenia severe congenital type 2 autosomal dominant, it is recommended to consult a dermatologist. Our test department, Genetics, specializes in genetic testing and can provide you with accurate and reliable results.
Pre Test Information
Before undergoing the GFI1 Gene Neutropenia severe congenital type 2 autosomal dominant NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by GFI1 Gene Neutropenia severe congenital type 2 autosomal dominant.
At DNA Labs UAE, we are committed to providing high-quality genetic testing services. Our team of experts utilizes advanced NGS technology to ensure accurate and reliable results. If you have any questions or would like to schedule a genetic test, please contact us.
Test Name | GFI1 Gene Neutropenia severe congenital type 2 autosomal dominant Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for GFI1 Gene Neutropenia, severe congenital type 2, autosomal dominant NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GFI1 Gene Neutropenia, severe congenital type 2, autosomal dominant NGS Genetic DNA Test gene GFI1 |
Test Details |
The GFI1 gene is associated with a rare genetic disorder called severe congenital neutropenia type 2 (SCN2). This disorder is inherited in an autosomal dominant manner, which means that a mutation in one copy of the GFI1 gene is enough to cause the condition. Neutropenia refers to a low level of neutrophils, which are a type of white blood cell involved in fighting off infections. In SCN2, individuals have a severe form of neutropenia from birth, which makes them highly susceptible to recurrent bacterial infections. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes. In the case of SCN2, NGS genetic testing can be used to identify mutations in the GFI1 gene. This testing can help confirm a diagnosis and determine the specific mutation present in an affected individual or their family members. Knowing the specific mutation can be important for genetic counseling, as it can help predict the likelihood of passing the condition on to future generations. Additionally, it can aid in the development of personalized treatment strategies for individuals with SCN2. |